Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET.
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT senior writer of medicine and editorial director of events Matthew Herper and STAT national biotech reporter Damian Garde sit down to discuss what is next for developments in gene therapy. They will discuss new potential treatments for diseases ranging from sickle cell anemia to muscular dystrophy, and of course be taking your questions live.